Aligos gets $125mm in Series B financing

14:40 EST 15 Jan 2020 | Elsevier Business Intelligence

Aligos Therapeutics Inc. (therapies for hepatic diseases and viral infections) raised $125mm in an oversubscribed Series B fi...

Original Article: Aligos gets $125mm in Series B financing


More From BioPortfolio on "Aligos gets $125mm in Series B financing"

Quick Search

Relevant Topics

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...